Viatris (VTRS): CEO bought ~$536K
Scott Andrew Smith, CEO at Viatris, bought ~$536K of Viatris shares.
- ~$536K
- Approx. value · 60K sh @ $8.94
- 293K
- Holds after · shares reported
- Traded
- May 12, 2025
- Filed
- May 14, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 25, 2025CongressDisclosed purchase of VTRS — reported range $1,001 - $15,000
- Mar 20, 2025FDAFDA drug approval: Difluprednate
- Mar 31, 2025CongressDisclosed partial sale of VTRS — reported range $1,001 - $15,000
- Apr 8, 2025CongressDisclosed sale of VTRS — reported range $1,001 - $15,000
- May 12, 2025 · this disclosureInsiderCEO purchased ~$536K of VTRS shares in the open market
What came next
- May 20, 2025FDAFDA drug approval: Emtricitabine, Rilpivirine and Tenofovir Disoproxil Fumarate
- May 28, 2025FDAFDA drug approval: Methylnaltrexone Bromide
- Jun 30, 2025FDAFDA drug approval: Amphotericin B
- Jul 22, 2025FDAFDA drug approval: Darunavir
- Aug 8, 2025FDAFDA drug approval: Iron Sucrose
- Aug 12, 2025InsiderCEO purchased ~$220K of VTRS shares in the open market
- Aug 19, 2025FDAFDA drug approval: Paclitaxel
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Viatris
For Viatris, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VTRS page.
Other recent filings by Scott Andrew Smith, Chief Executive Officer
The full history of Scott Andrew Smith, Chief Executive Officer is on the profile page.
How this filing works
Explore the data
Common questions
Which Viatris (VTRS) insider traded, and how much?
Scott Andrew Smith, CEO at Viatris, bought ~$536K of Viatris shares. 60K shares at $8.94, open market.
When did it happen, and when was it made public?
Traded: May 12, 2025. Filed: May 14, 2025. That is 2 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Viatris recently?
For Viatris, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the VTRS page.
Does this mean VTRS stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Viatris
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 11, 2026
Everything OQRO holds on this company is on its VTRS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
